✦ LIBER ✦

Analysis of biomarkers (P PTEN, and IGF-IR) after preoperative systemic treatment with the combination of docetaxel and trastuzumab in patients with locally advanced HER2-overexpressing breast cancer (Tokai Breast Cancer Clinical Research Group: TBCRG)

✍ Scribed by H. Iwata; M. Sawaki; Y. Sato; M. Wada; T. Toyama; E. Sasaki; Y. Yatabe; T. Imai

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of preoperative systemic

✍ Masataka Sawaki; Hiroji Iwata; Yasuyuki Sato; Masaki Wada; Tatsuya Toyama; Eiich 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 635 KB

P.39 Docetaxel plus epirubicin (DE) vs d

✍ Vamvakas, L.; Karampeazis, A.; Ardavanis, A.; Souglakos, I.; Kalbakis, K.; Varda 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB